v3.25.4
Schedule I — Condensed Financial Information of Registrant - Condensed Statements of Operations and Comprehensive Loss (Details) - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Operating Expenses:      
Research and development $ (220,904,000) $ (234,504,000) $ (265,868,000)
Loss from operations (229,434,000) (282,117,000) (366,573,000)
Interest income 33,048,000 37,105,000 39,797,000
Interest expenses (5,209,000) (2,254,000) 0
Other (expense) income, net 3,540,000 5,300,000 7,006,000
Net loss (175,537,000) (257,103,000) (334,620,000)
Other comprehensive (loss) income, net of tax of nil:      
Other comprehensive income, tax 0 0 0
Foreign currency translation adjustments (20,818,000) 12,889,000 11,941,000
Comprehensive loss (196,355,000) (244,214,000) (322,679,000)
Parent Company      
Operating Expenses:      
Research and development (30,000) (8,000) (82,000)
General and administrative (13,590,000) (20,275,000) (16,958,000)
Loss from operations (13,620,000) (20,283,000) (17,040,000)
Interest income 21,695,000 28,176,000 30,840,000
Interest expenses (90,000) 0 0
Other (expense) income, net (1,145,000) (5,438,000) 4,029,000
Profit before income tax and equity in loss of subsidiaries 6,840,000 2,455,000 17,829,000
Equity in loss of subsidiaries (182,377,000) (259,558,000) (352,449,000)
Net loss (175,537,000) (257,103,000) (334,620,000)
Other comprehensive (loss) income, net of tax of nil:      
Other comprehensive income, tax 0 0 0
Foreign currency translation adjustments (20,818,000) 12,889,000 11,941,000
Comprehensive loss $ (196,355,000) $ (244,214,000) $ (322,679,000)